Literature DB >> 7635990

Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice.

S Levak-Frank1, H Radner, A Walsh, R Stollberger, G Knipping, G Hoefler, W Sattler, P H Weinstock, J L Breslow, R Zechner.   

Abstract

In extrahepatic tissues lipoprotein lipase (LPL) hydrolyzes triglycerides thereby generating FFA for tissue uptake and metabolism. To study the effects of increased FFA uptake in muscle tissue, transgenic mouse lines were generated with a human LPL minigene driven by the promoter of the muscle creatine kinase gene. In these mice human LPL was expressed in skeletal muscle and cardiac muscle, but not in other tissues. In proportion to the level of LPL overexpression, decreased plasma triglyceride levels, elevated FFA uptake by muscle tissue, weight loss, and premature death were observed in three independent transgenic mouse lines. The animals developed a severe myopathy characterized by muscle fiber degeneration, fiber atrophy, glycogen storage, and extensive proliferation of mitochondria and peroxisomes. This degree of proliferation suggests that FFA play an important role in the biogenesis of these organelles. Our experiments indicate that LPL is rate limiting for the supply of muscle tissue with triglyceride-derived FFA. Improper regulation of muscle LPL can lead to major pathological changes and may be important in the pathogenesis of some human myopathies. Muscle-specific LPL transgenic mouse lines will serve as a useful animal model for the investigation of myopathies and the biogenesis of mitochondria and peroxisomes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635990      PMCID: PMC185285          DOI: 10.1172/JCI118145

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Familial centronuclear myopathy: a clinical and pathological study.

Authors:  J H Sher; A B Rimalovski; T J Athanassiades; S M Aronson
Journal:  Neurology       Date:  1967-08       Impact factor: 9.910

2.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

3.  A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma.

Authors:  C D Banner; M Göttlicher; E Widmark; J Sjövall; J J Rafter; J A Gustafsson
Journal:  J Lipid Res       Date:  1993-09       Impact factor: 5.922

Review 4.  Lipolytic enzymes and plasma lipoprotein metabolism.

Authors:  P Nilsson-Ehle; A S Garfinkel; M C Schotz
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with increased perinatal mortality and reduced plasma very low density lipoprotein of normal size.

Authors:  E Zsigmond; E Scheffler; T M Forte; R Potenz; W Wu; L Chan
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

6.  Photoaffinity labeling and fatty acid permeation in 3T3-L1 adipocytes.

Authors:  B L Trigatti; D Mangroo; G E Gerber
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

7.  Regional myocardial free fatty acid extraction in normal and ischemic myocardium.

Authors:  K Vyska; H J Machulla; W Stremmel; D Fassbender; W H Knapp; G Notohamiprodjo; U Gleichmann; H Meyer; E J Knust; R Körfer
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

8.  Induction of aP2 gene expression by nonmetabolized long-chain fatty acids.

Authors:  P A Grimaldi; S M Knobel; R R Whitesell; N A Abumrad
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

9.  Human lipoprotein lipase complementary DNA sequence.

Authors:  K L Wion; T G Kirchgessner; A J Lusis; M C Schotz; R M Lawn
Journal:  Science       Date:  1987-03-27       Impact factor: 47.728

10.  Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21.

Authors:  R S Sparkes; S Zollman; I Klisak; T G Kirchgessner; M C Komaromy; T Mohandas; M C Schotz; A J Lusis
Journal:  Genomics       Date:  1987-10       Impact factor: 5.736

View more
  61 in total

1.  Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

Authors:  Xue Xue; Song You; Qiang Zhang; Yan Wu; Guo-Zhang Zou; Paul C Wang; Yu-Liang Zhao; Yan Xu; Lee Jia; Xiaoning Zhang; Xing-Jie Liang
Journal:  Mol Pharm       Date:  2012-02-13       Impact factor: 4.939

Review 2.  Organelle dynamics and dysfunction: A closer link between peroxisomes and mitochondria.

Authors:  F Camões; N A Bonekamp; H K Delille; M Schrader
Journal:  J Inherit Metab Dis       Date:  2008-12-12       Impact factor: 4.982

3.  Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.

Authors:  Barbara Gürtl; Dagmar Kratky; Christian Guelly; Lefeng Zhang; Gregor Gorkiewicz; Suman Kumar Das; Kuppusamy Palaniappan Tamilarasan; Gerald Hoefler
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Lipase maturation factor 1 is required for endothelial lipase activity.

Authors:  Osnat Ben-Zeev; Maryam Hosseini; Ching-Mei Lai; Nicole Ehrhardt; Howard Wong; Angelo B Cefalù; Davide Noto; Maurizio R Averna; Mark H Doolittle; Miklós Péterfy
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

5.  The tissue distribution of lipoprotein lipase determines where chylomicrons bind.

Authors:  Roger Savonen; Michaela Hiden; Magnus Hultin; Rudolf Zechner; Sanja Levak-Frank; Gunilla Olivecrona; Thomas Olivecrona
Journal:  J Lipid Res       Date:  2015-01-14       Impact factor: 5.922

6.  Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase.

Authors:  P H Weinstock; S Levak-Frank; L C Hudgins; H Radner; J M Friedman; R Zechner; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

7.  Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia.

Authors:  M Merkel; P H Weinstock; T Chajek-Shaul; H Radner; B Yin; J L Breslow; I J Goldberg
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Lipoprotein Lipase Deficiency Impairs Bone Marrow Myelopoiesis and Reduces Circulating Monocyte Levels.

Authors:  Chuchun L Chang; Itsaso Garcia-Arcos; Rakel Nyrén; Gunilla Olivecrona; Ji Young Kim; Yunying Hu; Rishi R Agrawal; Andrew J Murphy; Ira J Goldberg; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-25       Impact factor: 8.311

9.  Cleavage of protein kinase D after acute hypoinsulinemia prevents excessive lipoprotein lipase-mediated cardiac triglyceride accumulation.

Authors:  Min Suk Kim; Fang Wang; Prasanth Puthanveetil; Girish Kewalramani; Sheila Innis; Lucy Marzban; Susan F Steinberg; Travis D Webber; Timothy J Kieffer; Ashraf Abrahani; Brian Rodrigues
Journal:  Diabetes       Date:  2009-11       Impact factor: 9.461

10.  Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids.

Authors:  Nigel Turner; Krit Hariharan; Jennifer TidAng; Georgia Frangioudakis; Susan M Beale; Lauren E Wright; Xiao Yi Zeng; Simon J Leslie; Jing-Ya Li; Edward W Kraegen; Gregory J Cooney; Ji-Ming Ye
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.